TAKIPRIL SOLUTION FOR INJECTION 20MG/ML
Product details
Registration number: SIN16326P
Classification: Prescription Only
Active ingredients: Prilocaine Hydrochloride
Strength: 20.00 mg/ml
Dosage form: INJECTION, SOLUTION
Route: INTRATHECAL
Registrant: B. BRAUN SINGAPORE PTE LTD
ATC code: N01BB04
HSA approval date: 17 September 2021
Manufacturer(s): Sintetica SA
Manufacturing country/countries: SWITZERLAND
What are the HSA registration number and classification for TAKIPRIL SOLUTION FOR INJECTION 20MG/ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16326P
Classification: Prescription Only
What active ingredients and strength are recorded for TAKIPRIL SOLUTION FOR INJECTION 20MG/ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Prilocaine Hydrochloride
Strength: 20.00 mg/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for TAKIPRIL SOLUTION FOR INJECTION 20MG/ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: INTRATHECAL
Who is the recorded registrant for TAKIPRIL SOLUTION FOR INJECTION 20MG/ML?
According to the HSA dataset updated 7 August 2026:
Registrant: B. BRAUN SINGAPORE PTE LTD
Which manufacturers and countries are listed for TAKIPRIL SOLUTION FOR INJECTION 20MG/ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Sintetica SA
Manufacturing country/countries: SWITZERLAND
Where can I look up TAKIPRIL SOLUTION FOR INJECTION 20MG/ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16326P or the exact product name TAKIPRIL SOLUTION FOR INJECTION 20MG/ML. The general register link does not preselect this product.
What are the source dates for this TAKIPRIL SOLUTION FOR INJECTION 20MG/ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this TAKIPRIL SOLUTION FOR INJECTION 20MG/ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16326P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)